Ambrus, J.L., Ambrus, C.M., Back, N., Sokal, J.E., AND Collins, G.L.: Clinical and experimental studies on fibrinolytic enzymes. Ann. N. Y. Acad. Sc., 68: 97, 1957.
2.
Back, N., Ambrus, J.L., Goldstein, S., AND Harrison, J.W.E. : In vivo fibrinolytic activity and pharmacology of various plasmin (fibrinolysin) preparations. Circulation Res., 4: 440, 1956.
3.
Back, N., Ambrus, J.L., Simpson, C.L., AND Shulman S.: Study on the effect of streptokinase-activated plasmin (fibrinolysin) on clots in various stages of organization. J. Clin. Invest., 37: 864, 1958.
4.
Moser, K.M.: Thrombolysis with fibrinolysin (plasmin). New therapeutic approach to thromboembolism . J. A. M. A., 167: 1695, 1958.
5.
Sokal, J.E., Ambrus, J.L., AND Ambrus, C.M.: Treatment of thrombosis with fibrinolysin (plasmin). J. A. M. A., 168: 1314, 1958.
6.
Sussman, B.J. , AND Fitch, T.S.P.: Thrombolysis with fibrinolysin in cerebral arterial occlusion. J. A. M. A., 167: 1705, 1958 .
7.
Ploug, J., AND Kjeldgaard, N.O. : Urokinase. An activator of plasminogen from human urine. I. Isolation and properties. Biochim. et Biophys. Acta, 24: 278, 1957.
8.
Fletcher, A.P. , Sherry, S., Alkjaersig, N., AND Smyrniotis , F.E.: The maintenance of a sustained thrombolytic state in man. II. Clinical observations on patients with myocardial infarction and other thromboembolic disorders. J. Clin. Invest., 38: 1111, 1959.
